Genovate Biotechnology Co., LTD.

ACTIVE

No.1, First Industrial Rd, Hsin-Chu Expanded Park, 台湾 Taipei, 台湾省, Taiwanwww.genovate-bio.comPublic11–50 employeesEstablished: 1995-01-01

Also known as:

GBL

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1995

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

38.5%

Phase 3

15.4%

Phase 4

15.4%

Phase 2

7.7%

Trial Status Distribution

Completed

53.9%

Terminated

15.4%

Unknown

30.8%

Clinical Trials

Trials sponsored by this organization (13)

BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers

Phase 1

Completed

interventional

Nov 202340 participants

BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Phase 1

Completed

interventional

Jul 202225 participants

Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers

Phase 1

Terminated

interventional

Apr 202219 participants

Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Phase 1

Completed

interventional

Feb 201928 participants

Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Phase 1

Completed

interventional

Mar 201821 participants

Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication

Phase 3

Terminated

interventional

Mar 201614 participants

Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis

Phase 2

Completed

interventional

Jul 201532 participants

Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study

Unknown

observational

Jan 200940 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations